EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Activity of the Di-Substituted Urea-Derived Compound I-17 in Leishmania In Vitro Infections

José Vitorino Dos Santos, Jorge Mansur Medina, Karina Luiza Dias Teixeira, Daniel Marcos Julio Agostinho, Michael Chorev, Aurora Diotallevi iD, Luca Galluzzi iD, Bertal Huseyin Aktas, Ulisses Gazos Lopes

Pathogens · 2024

DOI: 10.3390/pathogens13020104 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2024. Verfasst von José Vitorino Dos Santos und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Parasitology, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro 21941…. Hauptthemen laut MEDLINE: Antiprotozoal Agents, Macrophages, Urea, Leishmania. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIAID NIH HHS, NIH/NCI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protein synthesis has been a very rich target for developing drugs to control prokaryotic and eukaryotic pathogens. Despite the development of new drug formulations, treating human cutaneous and visceral Leishmaniasis still needs significant improvements due to the considerable side effects and low adherence associated with the current treatment regimen. In this work, we show that the di-substituted urea-derived compounds I-17 and 3m are effective in inhibiting the promastigote growth of different Leishmania species and reducing the macrophage intracellular load of amastigotes of the Leishmania (L.) amazonensis and L. major species, in addition to exhibiting low macrophage cytotoxicity. We also show a potential immunomodulatory effect of I-17 and 3m in infected macrophages, which exhibited increased expression of inducible Nitric Oxide Synthase (NOS2) and production of Nitric Oxide (NO). Our data indicate that I-17, 3m, and their analogs may be helpful in developing new drugs for treating leishmaniasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiprotozoal AgentsMacrophagesUreaLeishmaniaAnimalsMiceNitric OxideNitric Oxide Synthase Type IIHumansLeishmaniasis

Stichwörter der Autor:innen

Leishmaniasisdi-substituted urea-derivativeseIF2αeIF2α kinase activatorstranslation initiation

Substanzen

Antiprotozoal AgentsUreaNitric OxideNitric Oxide Synthase Type II

Autor:innen und Institutionen

  • Laboratory of Molecular Parasitology, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro 21941-902, Brazil.
  • Department of Cell Biology, University of Virginia, Pinn Hall, Charlottesville, VA 22908, USA.
  • Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Department of Biomolecular Sciences, University of Urbino Carlo Bo, 61029 Urbino, Italy.

ORCID-Profile: Aurora Diotallevi, Luca Galluzzi

Förderung

  • NCI NIH HHS
  • NIAID NIH HHS
  • NIH/NCI
  • Department of Biomolecular Sciences of the University of Urbino
  • Fundação Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ)
  • NIH/NIAID

Zitieren

APA

Dos Santos, J. V., Medina, J. M., Dias Teixeira, K. L., Agostinho, D. M. J., Chorev, M., Diotallevi, A., Galluzzi, L., Aktas, B. H., & Gazos Lopes, U. (2024). Activity of the Di-Substituted Urea-Derived Compound I-17 in Leishmania In Vitro Infections. Pathogens. https://doi.org/10.3390/pathogens13020104

Vancouver

Dos Santos JV, Medina JM, Dias Teixeira KL, Agostinho DMJ, Chorev M, Diotallevi A, et al. Activity of the Di-Substituted Urea-Derived Compound I-17 in Leishmania In Vitro Infections. Pathogens. 2024. doi:10.3390/pathogens13020104

BibTeX
@article{DosSantos2024,
  author = {Dos Santos, José Vitorino and Medina, Jorge Mansur and Dias Teixeira, Karina Luiza and Agostinho, Daniel Marcos Julio and Chorev, Michael and Diotallevi, Aurora and Galluzzi, Luca and Aktas, Bertal Huseyin and Gazos Lopes, Ulisses},
  title = {Activity of the Di-Substituted Urea-Derived Compound I-17 in Leishmania In Vitro Infections},
  journal = {Pathogens},
  year = {2024},
  doi = {10.3390/pathogens13020104}
}
Kostenlos starten →